<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0061">
 <label>61</label>
 <element-citation publication-type="journal" id="sbref0060">
  <person-group person-group-type="author">
   <name>
    <surname>McBride</surname>
    <given-names>J.M.</given-names>
   </name>
   <name>
    <surname>Lim</surname>
    <given-names>J.J.</given-names>
   </name>
   <name>
    <surname>Burgess</surname>
    <given-names>T.</given-names>
   </name>
  </person-group>
  <article-title>Phase 2 randomized trial of the safety and efficacy of MHAA4549A, a broadly neutralizing monoclonal antibody, in a human influenza A virus challenge model</article-title>
  <source>Antimicrob Agents Chemother</source>
  <volume>61</volume>
  <year>2017</year>
 </element-citation>
</ref>
